Avalo Therapeutics Inc. (AVTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Avalo Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.12
+5.48% today
Market cap
$362M
Overall quality
56/100
Kronos AI 30-day
+164.5%
8 of 8 simulated paths end higher
Avalo Therapeutics Inc. (AVTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $362M. It trades at $7.12, up 5.48% today. Its overall quality score is 56 out of 100, ranked against the whole US market. 7 analysts' average target of $28.83 implies +304.9% from today's price. Kronos AI's 30-day forecast is +164.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $28.83 |
| Low – high | $10.00 – $60.00 |
| Analysts | 7 |
| Upside to average | +304.9% |
Kronos AI 30-day forecast
| Expected close | $17.86 (+164.5%) |
| Likely range | +149.3% … +182.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 92 |
| Growth | 34 |
| Overall | 56 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.